SWITGLIM M 1/1000 MG (Glimepiride (1mg) + Metformin (1000mg))

Switglim-M 1/1000 Tablet PR is classified as an oral anti-diabetic medication that combines two active ingredients to manage type 2 diabetes mellitus in adult patients. This medication aids in regulating blood glucose levels, which is essential for individuals dealing with diabetes. It is important to take this tablet with food to optimize its effects. Patients are advised to maintain a consistent schedule by taking the medication at the same time each day for maximum efficacy. The prescribing physician will determine the initial dosage and may modify it based on the patient’s response and current blood glucose readings. It is crucial to continue taking this medication, even during periods when one feels well or blood sugar levels appear stable, as discontinuation can lead to elevated blood sugar levels, posing serious health risks, including kidney damage, vision impairment, neuropathy, and potential limb loss. This medication is part of a broader management plan, which should also incorporate a balanced diet, regular physical activity, and weight management as directed by a healthcare professional. Lifestyle adjustments play a significant role in effective diabetes management. One of the most frequently observed adverse effects is hypoglycemia, characterized by low blood sugar levels. Patients are advised to familiarize themselves with the symptoms of hypoglycemia, including feelings of dizziness, sweating, shaking, and headache, and understand how to address these. Eating regular meals and having a quick source of sugar on hand, such as fruit juice or candy, can help prevent these situations. Alcohol consumption is discouraged, as it may heighten the risk of blood sugar dropping too low. Other potential side effects may include changes in taste, nausea, gastrointestinal upset, headaches, and respiratory infections. In some cases, patients may experience weight gain while on this medication.